The Ministry of Chemicals and Fertilizers (MoC&F) on November 13, 2026, issued a notification regarding strict monitoring of the implementation of Trade Margin rationalisation on 137 Anti-Cancer Drugs.
The following has been stated: -
•The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has directed State Drug Controllers to ensure strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, notified vide Gazette Order dated October 17, 2026, with revised Maximum Retail Prices (MRPs) effective from November 09, 2026.
•Manufacturers, retailers, dealers, stockists, hospitals and medical institutions must comply with the revised prices and prominently display updated price lists.
•Violations may attract overcharging proceedings under the Drugs (Prices Control) Order (DPCO), 2013. State Drug Controllers must submit Action Taken Reports to NPPA by November 16, 2026.
The detailed notification is given in the document below.
[Notification No.: 2335722]
